Aura Biosciences, Inc. (AURA)
NASDAQ: AURA · Real-Time Price · USD
8.20
+0.09 (1.11%)
Dec 20, 2024, 4:00 PM EST - Market closed
Aura Biosciences Stock Forecast
Stock Price Forecast
The 4 analysts with 12-month price forecasts for Aura Biosciences stock have an average target of 23, with a low estimate of 22 and a high estimate of 24. The average target predicts an increase of 180.49% from the current stock price of 8.20.
Analyst Consensus: Strong Buy
* Price targets were last updated on Nov 14, 2024.
Analyst Ratings
The average analyst rating for AURA stock from 4 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jul '24 | Aug '24 | Sep '24 | Oct '24 | Nov '24 | Dec '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Buy | 2 | 1 | 1 | 2 | 2 | 2 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 4 | 3 | 3 | 4 | 4 | 4 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $22 | Strong Buy | Reiterates | $22 | +168.29% | Nov 14, 2024 |
| Scotiabank | Scotiabank | Buy Maintains $20 → $23 | Buy | Maintains | $20 → $23 | +180.49% | Oct 18, 2024 |
| BTIG | BTIG | Strong Buy Maintains $21 → $24 | Strong Buy | Maintains | $21 → $24 | +192.68% | Oct 18, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $21 → $22 | Strong Buy | Maintains | $21 → $22 | +168.29% | Oct 18, 2024 |
| JMP Securities | JMP Securities | Buy Maintains $19 → $23 | Buy | Maintains | $19 → $23 | +180.49% | Sep 13, 2024 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
-1.71
from -1.93
EPS Next Year
-2.09
from -1.71
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | n/a | n/a | n/a | |||
| Avg | n/a | n/a | n/a | |||
| Low | n/a | n/a | n/a |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | - | - | - | |||
| Avg | - | - | - | |||
| Low | - | - | - |
EPS Forecast
| EPS | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | -1.73 | -1.94 | -1.99 |
| Avg | -1.71 | -2.09 | -2.08 |
| Low | -1.68 | -2.47 | -2.17 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | - | - | - |
| Avg | - | - | - |
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.